Synthesis, Characterization and Biological Activity of Some Complexes of Some New Amino Acid Derivatives N-[(Benzoyl amino)-Thioxomethyl]-Amino Acid(HL)
Synthesis, Characterization and Biological Activity of Some Complexes of Some New Amino Acid Derivatives N-[(Benzoyl amino)-Thioxomethyl]-Amino Acid(HL)
Journal of the Korean Chemical Society. 2010. Oct, 54(5): 506-514
Copyright © 2010, The Korean Chemical Society
  • Received : December 04, 2009
  • Accepted : June 01, 2010
  • Published : October 20, 2010
Export by style
Cited by
About the Authors
Dhafir M. H. Al-Mudhaffar
Dawood S. Al-Edani
Suma M. Dawood

A new series of ligands N-[(benzoylamino)-thioxomethyl]-amino acid (HL) were synthesized by reaction of benzoylisothiocyanate with various amino acids namely aspartic acid [BATA] ( 1 ), glutamic acid [BATG] ( 2 ), methionine [BATM] ( 3 ), leucine [BATL] ( 4 ), and tryptophan [BATT] ( 5 ). The ligands were characterized by elemental analysis, IR and NMR spectra. Some transition metal complexes (ML 2 ) for these ligands ( 6 - 8 ) were prepared; [M=Cu(II), Co(II), or Ni(II)], and characterized by elemental analysis, IR and 1 H NMR spectra. Antibacterial study showed that all the ligands have no antibacterial activity, whereas (ML 2 ) complexes; [M = Cu(II), Co(II), or Ni(II)] have antibacterial activity towards (Gram-ive) Escherichia (NCTC5933) and (Gram +ive) Staphylococcus (NCTC6571) and have no toxicity on (BALB/C) Albino mice.
It is well verified that many transition metals- 1 , 2 and rare earth metals-amino acids complexes 3 have considerable biological activity, such as antitumor properties. Ga(NO 3 ) 3 has exhibited clinical activity against lymphomas 4 and bladder carcinomas. 5 , 6 Ruthenium complexes, such as ammine, amine, and heterocyclic complexes of ruthenium (III) exhibit inhibition of DNA replication. 7 Many Rh (II)- and other transition metal-complexes have shown good antitumor activities. 8 Transition metal complexes of thiourea derivatives of glycine, 9 , 10 hisitidine, phenylalanine, serine, alanine and cysteine have been prepared and characterized. 11
A new series of amino acid esters bearing coumarin were synthesized and evaluated, in vitro , against HIV-1 and bovine viral diarrhea virus (BVDV). 12
J. David invented method producing hydroxyamino-acids, esters, or derivative, thereof , is provided 13 through regioselective or enzymatic hydrolysis followed by rearrangement for substituted β-ketodiester giving the final product. A convenient microwave assisted synthesis of N-glycosyl aminoacids, in which complying reaction of glycosylamines with Fmoc-protected aspartic acid, by microwave approach was described. 14
Recently a novel synthetic method for isomeric peptides through an appropriate linkage of L-selenomethionine or Se-Methyl-L-selenocysteine with L-glutamic acid producing peptides of L-Selenomethionine or Se-Methyl-L-selenocysteine which have among other properties ,capabilities to prevent, reduce hair fall and promote hair growth. 15
A series of antibacterial and antifungal amino acid-derived compounds and their Co(II)-, Cu(II)-, Ni(II)-, and Zn(II)-complexes; [M(L)(H 2 O) 4 ]Cl have been synthesized and characterized by elemental analysis, molar conductance, magnetic moments, IR and electronic spectral measurements. The ligand (L) were derived by condensation of β-diketones with glycine, phenylalanine, valine and histidine. 16
Recently, a series of amino acid ester derivatives containing 5-fluorouracil were synthesized using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC·HCl) and N -hydroxybenzotriazole (HOBt) as a coupling agent. 17 The in vitro antitumor activity tests against leukaemia HL-60 and liver cancer BEL-7402 indicated that ( R )-ethyl 2-(2-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1-(2 H -yl-acetamido)-3-(4-hydroxyphenyl) propanoate showed more inhibitory effect against BEL-7402 than 5-FU. 17 A new non-natural arginine-like amino acid derivative with a sulfamoyl group in the side-chain were synthesized by Sulfamoylation of the L-ornithine methyl ester side-chain generates a non-natural arginine isostere. 18 Vivek Kumar et al synthesized a new series of functionalized amino acid derivatives N-substituted-1-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-phenyl-5-oxazo lidine carboxamide and 1-N-substituted-3-amino-2-hydroxyl-3-phenylpropane-1-carboxamide. 19
The synthesis, and characterization of some new series of transition metal complexes of ligands; N-[(Benzoylamino)thioxomethyl] amino acid (HL) where (amino acid = apartic acid, glutamic acid, metheonine, leucine, or tryptophan) are reported here.
- Chemicals
All solvents are from G.C.C. D,L-Amino acids are from Merck or BDH. Transition metal chlorides are from Merck. Sodium Hydroxide and Benzoyl Chloride are from Fluka. Bilogical study was accomplished by using LTF-Uni Jemp Autoclave for sterilizing and Escherichia (NCTC 5933) coli and Staphylococcus aureus (NCTC 6571) for biological activity study of the prepared compounds ( 1 - 8 ).
- Physical Measurements
The IR -spectra were recorded on Shimadzu FTIR -8400 spectrometer using KBr pellets in the range 4000 - 400 cm -1 . Elemental analysis were performed on EA 3000 A-Eurovector. 1 H NMR-spectra were recorded on Bruker Ultra shield 300 MHz using tetraflouroacetic acid and MeOD as solvents and TMS as internal standard.
- Synthesis of the ligands (HL)
(i) Preparation of the benzoylisothiocyante was done as described in the literature. 11 Equivalent molal ratios of benzoyl chloride and ammonium thiocyanate in acetone was refluxed for 1hr.,and worked up as the literature method to give pure filtrate. 11
(ii) preparation of N-[(benzoyl amino)thioxomethyl]-aspartic acid (BATA) ( 1 ) was carried out by applying the general procedure as in the literature, 11 by adding rapidly (0.01 mmol) of aspartic acid to the above solution in (i) to maintain vigorous reflux for 6 h. The resultant solid product was collected, washed with acetone and recrystallized using column chromatography with eluent (ethanol : chloroform = 4 : 1) giving a white solid. Yield (65%). m.p. = 273 - 275 ℃.
Similarly, the glutamic acid-, leucine-, and tryptophanderivatives; i.e compounds 2 - 5 were obtained applying similar procedure as in (ii) above. Physical properties for compounds 1 - 5 are given in 1 .
- Synthesis of the metal complex compounds (6-8) 11
1.24 mmol of the ligand (HL) was dissolved in 25 mL of pure methanol containing 1.24 mmol of NaOH. A solution of metal chloride; (0.62 mmol); MCl 2 {M:Co(II),Cu(II) or Ni(II)}, in methanol was added dropwise over the ligand (HL) basic solution, and the precipitate appeared immediately. After stirring the mixture at room temperature for 2 h, the precipitate was collected by filtration, washed with methanol and dried under vacuum. Further purification applying column chromatography (methanol / chloroform = 4.5 : 0.5) gave the purest solid products with melting points shown in 1 .
- Synthesis of the ligands
The synthesis of the ligands 1 - 5 requires firstly the preparation of benzoylisothiocyante, 9 and subsequent reactions with respective amino acid (HL) under reflux in acetone, as shown in 1 .
PPT Slide
Lager Image
Preparation of N-[(benzoyl amino-thioxomethyl)-amino acid (HL)
- Infrared spectra
The IR spectra for the ligands 1 - 5 shows similarity in some absorption frequencies: aromatic C-H stretching in the range 3000 - 3100 cm -1 , aliphatic C-H frequencies in the range 2750 - 2990 cm -1 . Broad and medium bands in the range 3250 - 3520 cm -1 are attributed to superimposed O-H and NH stretching bands. Band, due to strong V as (C=O) stretching occurred in the range 1691 - 1724 cm -1 and weaker V s (C=O) bands in the range 1490 - 1593 cm -1 . The characteristic band at ~ 1700 cm -1 ; for V as (C=O) shifts to lower frequencies upon complexation. The complexes 6 - 8 display both symmetric and asymmetric stretching vibrations of COO - 1390 - 1458 cm -1 and 1583 - 1635 cm -1 respectively associated with charged form of carboxylic group 20 which indicates the coordination of ligand carboxyl group with the metal ions; (Cu(II), Ni(II), Co(II), as bidentate chelate fashion in accordance with the work of Kabbani et al . 11 Other n (C=S), and n (C=O) (carbonyl group) either show no change or vary little in their frequencies, therefore indicating do not coordinate to the metal ions (Cu(II), Ni(II) or Co(II). (Metal-O) frequencies are out of scale of measurement. Fundamental infrared frequencies for ligands 1 - 5 , and complexes 6-8 are given in 2 . The elemental analysis and physical properties of ligands 1 - 5 and complexes 6 - 8 are shown in 1 .
Elemental analysis and physical properties of the ligands and complexes (1-8)
PPT Slide
Lager Image
Elemental analysis and physical properties of the ligands and complexes (1-8)
Fundamental stretching frequencies (cm-1) of the compounds (1-8)
PPT Slide
Lager Image
Fundamental stretching frequencies (cm-1) of the compounds (1-8)
- 1H NMR spectra
1H NMR spectra of the ligands (HL) : The 1 H NMR spectrum of N-[(benzoyl amino)thioxomethyl] aspartic acid [BATA]( 1 ) shows two single bands at 11.042 ppm and 10.799 ppm which are attributed to carboxylic protons of R-group and that attached to (α-CH), respectively. 11 , 17 A triplet band at 3.99, 4.01, 4.03 ppm attributed to α-CH-proton, which occurred as a triplet signal in N-[(benzoyl amino)thioxomelthyl] serine. 11 The ligand [BATT( 5 )] shows a characteristic indole- protons band, at 10.11 ppm (NH), which for free indole occured at 10.1 ppm, and in coumarine derivative occured at 9.03 ppm. 12 Other two doublet occur at 7.628, 7.602 ppm and 7.412,7.385 ppm due to two aromatic protons of tryptophan. Details of proton NMR data for the ligands 1 - 5 are shown in 3 .
1HNMR chemical shifts (ppm) of the ligands (1-5) and complexes (6-8)
PPT Slide
Lager Image
1HNMR chemical shifts (ppm) of the ligands (1-5) and complexes (6-8)
PPT Slide
Lager Image
1HNMR spectrum of the ligand (BATA) (1)
1H NMR spectra of complex compounds : ( a ) Bis-(benzoylaminothioxomethylaspartate) copper(II); [Cu(BATA) 2 ] ( 6 ) shows similar bands to that for free ligand [BATA( 1 )] except the disappearance of the carboxylic protons attached to (α-CH) at 10.799 ppm which indicates the coordination of the ligand to copper(II) ion via oxygens of carboxylate group which attached to α-carbon atom.
( b ) 1 H NMR spectra of bis-(benzoylaminothioxomethylmetheoninate) cobalt(II); [Co(BATM) 2 ] ( 7 ) showed similar band as that of free ligand [BATM( 3 )] except the disappearance of carboxylic proton band at ~ 10.9 ppm. Which indicates the coordination of Co(II) ion with carboxylate oxygens.
( c ) 1 H NMR spectra of bis-(benzoylaminothioxomethyltryptophanate) nickel(II); [Ni(BATT) 2 ] ( 8 ) shows similarly to the ligand [BATT( 5 )] bands except the disappearance of carboxylic proton at 11.045 ppm which also indicates the coordination via carboxylate oxygen atoms to the metal ion. Details of 1 H NMR spectra for the ligands 1 - 5 and complexes 6 - 8 are given in . 1 - 8 and 3 .
In accordance with the elemental analysis, IR and NMR spectra data, we suggest that the structure of the ligands 1 - 5 shown below, resembling the general formula which was also suggested by Kabbani et al , 11 and the metal ions; {Cu(II), Ni(II) or Co(II)} complex with the ligands 1-5 via α-carboxylic oxygen atoms, as (ML 2 complexes).
PPT Slide
Lager Image
Proton NMR spectra of BATG (2)
PPT Slide
Lager Image
1HNMR spectrum of the ligand (BATL) (3)
PPT Slide
Lager Image
1HNMR spectrum of the ligand (BATM) (4)
PPT Slide
Lager Image
1HNMR spectrum of the ligand (BATT) (5)
PPT Slide
Lager Image
1HNMR spectrum of the Cu(BATA)2 (6)
PPT Slide
Lager Image
1HNMR spectrum of the complex compound Co(BATM)2 (7)
PPT Slide
Lager Image
1HNMR spectrum of the complex compound Ni(BATT)2
- Biological activity
Antibacterial activity : By using agar diffusion technique, 21 , 22 the ligands antibacterial activities have been studied in vitro against Escherichia coli (NCTC 5933) and Staphylococcus aureus (NCTC 6571). All five ligands 1 - 5 have no effect upon these two types of bacteria ,whereas all the complexes 6 - 8 show antibacterial activities for both types. The results of bacterial growth inhibition data are given in 4 .
Growth inhibition by complexes (6‐8) against bacteria in (mm)
PPT Slide
Lager Image
(mm): millimeter
Minimal Inhibition Concentration (MIC) in (μg/mL) for complex compounds (6‐8)
PPT Slide
Lager Image
Minimal Inhibition Concentration (MIC) in (μg/mL) for complex compounds (68)
PPT Slide
Lager Image
Minimal Inhibitory Concentration (MIC) : 23 The minimal inhibitory concentrations for the complex compounds 6 - 8 show variation in concentrations depending upon complex type. The lowest (MIC) is for [Co(BATA) 2 ] ( 7 ), as indicated in 5 .
Medium Lethal Dose [LD50] : Twenty one white female Albino mice had been used for this study. They were divided into seven groups. One group (6 mice) was the control group which were given orally distilled water , whereas the other groups had been given orally (200, 400, 600, 800 and 1000) mg/kg doses of the complexes;[Cu(BATA) 2 ] ( 6 ), [Co(BATM) 2 ] ( 7 ), and [Ni(BATM) 2 ] ( 8 ). No toxicity effect for these complexes 6 - 8 has been observed after 72 h for all groups of mice; i.e. no lethal cases.
All the ligands 1 - 5 show no antibacterial activity, whereas the metal complexes of these ligands 6 - 8 have antibacterial activities. Besides, all these complex compounds 6 - 8 have no toxicity toward mice, hence they may replace cisplatin compounds as anticancer drugs which have toxic side effect for human being. To confirm such idea it needs further future study to be regarded as an invention if possible as anticancer drug.
We are grateful to Science College, Basra University (Iraq) for supporting the work. Our thanks to AL-Albeit University (Jordan) for doing elemental analysis and proton NMR measurements.
Canty A. J. , Steven E. A. 1981 Inorg. Chim. Acta 55 L 57 -    DOI : 10.1016/S0020-1693(00)90768-0
Rasenberg B. 1969 Nature 222 385 -    DOI : 10.1038/222385a0
Shukla S. K. 1983 Inorg. Chim. 94 144 -    DOI : 10.1016/S0020-1693(00)94607-3
Foster J. M. , ClageH-Carr K. , Hoth D. , Leyland-Jones B. 1986 Cancer Treat. Rep. 70 1311 -
Seligman P. A. , Crawford E. D. 1991 J. Natl .Cancer Inst. 83 1582 -    DOI : 10.1093/jnci/83.21.1582
Crawford E. D. , Saiers J. H. , Baker L. H. , Costanzi J. H. , Bu-Kowski R. M. 1991 Urology 38 355 -    DOI : 10.1016/0090-4295(91)80152-W
Kelman A. D. , Clarke M. J. , .Emonds S. D , Peresie H. J. , Hematol J. C. 1977 Oncol. 7 274 -
Clarke M. J. , Zhu F. , Frasca D. R. 1999 Chem. Reu. 99 2511 -    DOI : 10.1021/cr9804238
Yanping R. , Junfeng B. , Liufang W. , Jigui W. , Changu X. 1999 Syn. React. Inorg. Met-Org. Chem. 29 1171 -    DOI : 10.1080/00945719909349519
Junfeng B. , Jigui W. , Liufang W. , Yingnian R. 1998 Syn. React. Inorg. Met-Org. Chem. 28 917 -    DOI : 10.1080/00945719809351678
Kabbani A. T. , Ramadan H. , Hammud H. H. , Ghannoum A. M. , Mouneimne Y. 2005 J. Univ. Chem. Tech. and Met. 40 339 -
AL-Masoudi N. A. , AL-Masoudi I. A. , Ali I. A. I. , AL-Soud Y. A. , Saeed B. , LAColla P. 2006 Acta Pharm. 56 175 -
Rozzell J. D. 2007 United State Patent No. US 7, 301 B2
Paolini I. , Nuti F. , Chelli M. , Papini A. M. 2007 Tetrahedron Lett. 48 2901 -    DOI : 10.1016/j.tetlet.2007.02.087
Majeed M. , Nagabhushanam K. , Ramanujam R. , Chandramouli R. H. 2008 United State Patent Application Publication No. US 2008l0026017A1
Chohan Z. H. , Arif M. , Akhtar M. , Supuran C. T. 2006 Bioinorganic Chemistry and Applications Article ID 83131 2006 1 -    DOI : 10.1155/BCA/2006/83131
Xiong J. , Zhu H-Feng , Zhao Y-Juan , Lan Y-Jun , Jiang J-Wang , Yang J-Jing , Zhang S-Feng 2009 Molecules 14 3142 -    DOI : 10.3390/molecules14093142
De Marco R. , DI Gioia M. L. , Leggio A. , Liguori A. , Perri F. , Siciliano C. , Viscome M. C. 2009 Amino Acids    DOI : 10.1007/s00726-009-0267-2
Kumar V. , Mudugal M. M. , Rani N. , Jha A. , Jaggi M. , Singh A. T. , Sanna V. K. , Singh P. , Sharma P. K. , Rchhaiya R. I. , Burman A. C. 2009 J. Enzy. Inhib. Med. Chem. 24 763 -    DOI : 10.1080/14756360802362975
Silverstein R. M. , Webster F. X. , Kiemle D. G. 2005 Spectrometric Identification of Organic Compounds 7th edn. John Wiley & Sons,Inc. NJ, USA 109 - 103
Shank R. C. , Marmion D. G. 1979 Microbiology 12th ed. Churchil, Living Stone Edinbrg, London
Larry G. R. , Chatles W. S. , Barth R. 1981 Antimicrob. Agent & Chemother 19 1050 -    DOI : 10.1128/AAC.19.6.1050
Gerald C. J. , Barrie P. M. , Andrew G. F. , Anthong S. 1996 Practical Medical Microbiology 14th Ed. London